Javier Andrés Galnares‐Olalde

Neurologic adverse events among 704,003 first-dose recipients of the BNT162b2 mRNA COVID-19 vaccine in Mexico: A nationwide descriptive study

Miguel García‐Grimshaw, Santa Elizabeth Ceballos‐Liceaga, Laura E. Hernández‐Vanegas et al. · Clinical Immunology · 2021 · 109 citations · Full text

Vaccination, Vaccine Safety, Vaccine Development +8

Guillain-Barré syndrome is infrequent among recipients of the BNT162b2 mRNA COVID-19 vaccine

Miguel García‐Grimshaw, Anaclara Michel‐Chávez, Juan Mauricio Vera-Zertuche et al. · Clinical Immunology · 2021 · 79 citations · Full text

Vaccination, Vaccine Safety, Vaccine Development +8

The possibility of inventing new technologies in the detection of cancer by applying elements of the canine olfactory apparatus

Alan Pomerantz, Rubén Blachman-Braun, Javier Andrés Galnares‐Olalde et al. · Medical Hypotheses · 2015 · 20 citations

Canine Olfactory Apparatus, New Technologies, Veterinary Science +4

Incidence of <scp>Guillain–Barré</scp> syndrome following <scp>SARS‐CoV</scp> ‐2 immunization: Analysis of a nationwide registry of recipients of 81 million doses of seven vaccines

Miguel García‐Grimshaw, Javier Andrés Galnares‐Olalde, Omar Yaxmehen Bello‐Chavolla et al. · European Journal of Neurology · 2022 · 19 citations · Full text

Cytotoxic Lesions of the Corpus Callosum Caused by Thermogenic Dietary Supplements

Javier Andrés Galnares‐Olalde, Aldo J. Vázquez Mézquita, Gilberto Gómez-Garza et al. · American Journal of Neuroradiology · 2019 · 18 citations · Full text